Classification and basic pathology of Alzheimer disease.

Understanding the progression of brain pathology in aging remains a central challenge in neurology. Prior research has shown that protein accumulation and neuronal loss are common in many dementias. However, the specific patterns of these changes in Alzheimer disease are not fully understood. Established knowledge includes the role of amyloid-beta and tau proteins in neurodegeneration. This paper's contribution lies in mapping the stepwise progression of these lesions. The study addresses how different forms of protein accumulation relate to clinical symptoms. It also explores the genetic and anatomical factors influencing lesion distribution. The authors aim to clarify the heterogeneity of Alzheimer disease pathology. Their work builds on prior findings about the stereotyped spread of tau pathology.

The authors aim to define the core pathological features of Alzheimer disease. They focus on the classification of lesions based on protein accumulation patterns. The study seeks to clarify how amyloid-beta and tau pathology progress over time. The motivation comes from the need to distinguish Alzheimer disease from other dementias. The researchers also aim to describe the relationship between lesion type and clinical symptoms. They investigate whether the pattern of protein accumulation correlates with genetic risk factors. The study addresses the timing of synaptic loss and its possible link to amyloid-beta. The ultimate goal is to refine diagnostic criteria for Alzheimer disease subtypes.

The study uses histopathological analysis of brain tissue samples. Researchers examine the distribution of amyloid-beta and tau proteins. They classify amyloid-beta deposits into diffuse, focal, and stellate types. The analysis includes vessel walls of arteries, veins, and capillaries. Genetic factors like apoepsilon 4 alleles are considered in the analysis. The progression of tau pathology is mapped across brain regions. The study compares different clinical subtypes of Alzheimer disease. Researchers use standardized criteria to assess lesion severity and distribution.

Amyloid-beta accumulation follows a stepwise pattern in brain parenchyma. The presence of apoepsilon 4 alleles correlates with capillary wall involvement. Tau pathology progresses stereotypically from entorhinal cortex to isocortex. Neurofibrillary tangles form in neuron cell bodies, while neuropil threads appear in dendrites. Senile plaque neuritic coronas develop in axons. Neuronal loss is area-specific and varies across brain regions. Synaptic loss timing remains controversial, possibly linked to amyloid-beta oligomers. The study identifies multiple clinico-pathological subtypes of Alzheimer disease.

The authors propose that amyloid-beta and tau pathology follow distinct progression patterns. They suggest that apoepsilon 4 alleles influence vascular amyloid deposition. The stereotyped spread of tau pathology is presented as a key diagnostic feature. The study highlights the heterogeneity of Alzheimer disease subtypes. The authors emphasize the need for subtype-specific diagnostic criteria. They suggest that synaptic loss timing remains an open question. The study supports the classification of Alzheimer disease based on lesion types. The findings may inform future diagnostic and therapeutic approaches.